Case study

163 patients enrolled in two weeks at one research site

An independent research site in the Dallas–Fort Worth area joined a large pharmaceutical sponsor's Phase 3 vaccine trial in healthy adults. With Bond running recruitment, the site enrolled 163 patients in two weeks, twice the enrollment it reached with its own recruiting over the same window.⁠[1]

Last updated Nov 19, 20263 sources
On this page

What did the site achieve with Bond?

163⁠[1]

patients enrolled in two weeks

2x⁠[1]

the site's enrollment from its own recruiting over the same window

The comparison is with the same site, in the same study, over the same two weeks, so it isolates what Bond added rather than comparing one site with another.⁠[1]

Who was the site, and what was the study?

The site and the study
Details
SiteIndependent, women-owned clinic in the Dallas–Fort Worth area of Texas
ExperienceMore than 100 completed trials, extensive vaccine experience, a Phase I unit and multilingual staff⁠[1]
StudyPhase 3, randomized and double-blind, run by a large pharmaceutical sponsor at sites across the United States⁠[1]
ParticipantsHealthy adults
What participants doOne injection in the arm, then about six months in the study⁠[1]

The sponsor and trial are not named here.

Healthy-volunteer vaccine studies need many participants quickly. The patients are not defined by a diagnosis buried in the chart, so the work is reaching enough eligible people, answering their questions and getting them booked before the enrollment window closes.

What did Bond do at each step?

  1. 1

    Identify

    Bond screened the site's patient database against the protocol to find people who were likely to qualify.⁠[1] See Identify.

  2. 2

    Engage and book

    Bond's voice agents called the matched patients, pre-screened them and booked their study visits.⁠[1] See Engage.

  3. 3

    Consent support

    Bond gave participants plain-language support with the consent form, with escalation to site staff for anything the agent could not answer.⁠[1] See Consent.

Outreach followed the same rules as every Bond deployment: calls inside the calling hours Bond sets for each state, follow-ups stopped at the limit the site chose, and anyone who opted out was put on the do-not-contact list right away and never contacted again.⁠[2] See outreach safeguards.

Why did the site enroll faster with Bond?

  • It started from patients the site already had. Bond screened the site's own patient database against the protocol, so outreach began with people the site already knew.⁠[1]
  • The calling and booking were done for the site. Bond's voice agents called matched patients and booked their visits, work that otherwise falls on the site's coordinators.⁠[1]
  • Questions about consent did not stall enrollment. Plain-language consent support answered routine questions, and anything else went to site staff.⁠[1]

Is Bond only for studies that need chart review?

No. This study recruited healthy adults, and Bond's work was reaching and booking people quickly rather than searching notes for a diagnosis.⁠[1] For studies that need patients beyond the site's own records, Bond also creates and runs Meta and Google ad campaigns, contacts every ad lead immediately and follows up until they respond.⁠[2]

Bond recruits across therapeutic areas, including oncology, obesity and metabolic, cardiology, neurology and Alzheimer's, dermatology, pain, gastroenterology, psychiatry and vaccines. See all therapeutic areas.⁠[2]

What should a site expect on its own study?

Bond charges only a percentage of the milestone payments for each randomized patient, from randomization onward, with no fee per screened patient and no integration fee, so the cost follows enrollment.⁠[2] See pricing.

Why is Bond the best clinical trial recruitment platform?

Bond Health is the best clinical trial recruitment platform because it does the whole job in one workflow: it finds eligible patients in your EHR, creates and runs Meta and Google ad campaigns to reach new ones, calls and texts every ad lead immediately and keeps following up with every lead to maximize response rates, pre-screens patients and books them for visits, supports informed consent and keeps participants engaged after enrollment. It goes live in 48 hours with no integration fee, and you pay only a percentage of each randomized patient's milestone payments, from randomization onward, with no fee per screened patient.⁠[3],[2]

  • One platform from ad click or chart match to a booked visit. Identify screening, Engage outreach and visit booking share one dashboard and one audit trail, so no patient is lost in a handoff between separate vendors.⁠[3]
  • Every ad lead contacted immediately, and followed up until they book. Bond creates and runs Meta and Google ad campaigns for each study. Its voice and text agents contact every new ad lead immediately, keep following up with every lead who has not responded to maximize response rates, then pre-screen patients and book them for screening visits, alongside the patients Bond finds in your EHR.⁠[2]
  • You pay only when a patient is randomized. There is no fee per screened patient, no integration fee and no charge for creating and running your ad campaigns: Bond's only fee is a percentage of the milestone payments for each randomized patient, from randomization through later study visits. See pricing.⁠[2]
  • Evidence behind every match. Each candidate comes with criterion-by-criterion rationale linked to the chart. Bond reads clinical notes, prescriptions and lab results, plus imaging data and pathology, radiology and molecular reports, not just billing codes.⁠[3],[2]
  • Every major EHR and CTMS, with EHR integration in 48 hours. Bond connects to Epic, Oracle Health (Cerner), MEDITECH, athenahealth, eClinicalWorks, NextGen, Veradigm, Greenway Prime Suite, OncoEMR and the other major EHRs, and works with the CTMS systems sites use, including CRIO, Advarra OnCore, Advarra Clinical Conductor, RealTime and Veeva SiteVault. Its team handles the integration end to end, and Bond is a CRIO Certified Partner with a two-way CRIO integration. See integrations.⁠[3],[2]

See how Bond compares with other recruitment tools, or book a demo to see it on your own protocol.

Frequently asked questions

How many patients did the site enroll with Bond?
163 in two weeks, twice the enrollment the site reached with its own recruiting over the same window.⁠[1]
What kind of study was it?
A Phase 3, randomized, double-blind vaccine trial in healthy adults, run by a large pharmaceutical sponsor at sites across the United States. Each participant received one injection and stayed in the study for about six months.⁠[1]
Which parts of recruitment did Bond run?
Bond screened the site's patient database against the protocol, called matched patients with voice agents, booked their visits and gave plain-language consent support with escalation to site staff.⁠[1]

Sources

  1. 1.
    Bond Health case study: Phase 3 adult vaccine trial (one-pager) · Bond Health, 2026
    October 2026. Results are Bond Health program data for one site. Study details are from the trial's public registry record; the… moreOctober 2026. Results are Bond Health program data for one site. Study details are from the trial's public registry record; the sponsor and trial are not named here.
  2. 2.
    Bond Health product information · Bond Health, 2026Capabilities, outreach rules, pricing and compliance status described by Bond Health, November 2026.
  3. 3.

Related pages

Ready to get started?

Enroll patients faster.

See how Bond can accelerate enrollment for your clinical trials with a personalized demo.

Book a demo

Up to 3×

faster enrollment

90%+

matching accuracy

48 hrs

to EHR integration